Editas Medicine· @editasmed · X·· 2026-05-13AI 评分12
AI 导读
今天我们正在参加 TIDES USA 2026 会议，我们将通过口头报告分享更多关于我们的领先体内开发候选药物 EDIT-401 的信息。详情请访问 TIDES 网站：https://bit.ly/4neYOIi。 #TIDESUSA #invivo #geneediting #cardiovasculardisease
正文
Today we’re at the TIDES USA 2026 Meeting, where we’ll be sharing more information on our lead in vivo development candidate, EDIT-401, in an oral presentation. For details, visit the TIDES website: https://bit.ly/4neYOIi. #TIDESUSA #invivo #geneediting #cardiovasculardisease
来源：Editas Medicine · x.com